169 related articles for article (PubMed ID: 35601150)
1. TRIP13 Induces Nedaplatin Resistance in Esophageal Squamous Cell Carcinoma by Enhancing Repair of DNA Damage and Inhibiting Apoptosis.
Zhang LT; Ke LX; Wu XY; Tian HT; Deng HZ; Xu LY; Li EM; Long L
Biomed Res Int; 2022; 2022():7295458. PubMed ID: 35601150
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone receptor interactor 13 (TRIP13) overexpression associated with tumor progression and poor prognosis in lung adenocarcinoma.
Li W; Zhang G; Li X; Wang X; Li Q; Hong L; Shen Y; Zhao C; Gong X; Chen Y; Zhou J
Biochem Biophys Res Commun; 2018 May; 499(3):416-424. PubMed ID: 29567476
[TBL] [Abstract][Full Text] [Related]
3. TRIP13 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Di S; Li M; Ma Z; Guo K; Li X; Yan X
Pathol Res Pract; 2019 Jun; 215(6):152415. PubMed ID: 31064720
[TBL] [Abstract][Full Text] [Related]
4. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of thyroid hormone receptor interactor 13 is associated with human hepatocellular carcinoma.
Ju L; Li X; Shao J; Lu R; Wang Y; Bian Z
Oncol Rep; 2018 Dec; 40(6):3794-3802. PubMed ID: 30542731
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway.
Li N; Yu Y; Wang B
Am J Physiol Cell Physiol; 2020 Jul; 319(1):C93-C104. PubMed ID: 31747529
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
[TBL] [Abstract][Full Text] [Related]
9. miR-133a-3p suppresses cell proliferation, migration, and invasion and promotes apoptosis in esophageal squamous cell carcinoma.
Yin Y; Du L; Li X; Zhang X; Gao Y
J Cell Physiol; 2019 Aug; 234(8):12757-12770. PubMed ID: 30537034
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma.
Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869
[TBL] [Abstract][Full Text] [Related]
11. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.
Qiu F; Liu L; Lin Y; Yang Z; Qiu F
Anticancer Agents Med Chem; 2019; 19(8):1021-1028. PubMed ID: 30848215
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
13. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
14. TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis.
Zhang G; Zhu Q; Fu G; Hou J; Hu X; Cao J; Peng W; Wang X; Chen F; Cui H
Br J Cancer; 2019 Dec; 121(12):1069-1078. PubMed ID: 31740732
[TBL] [Abstract][Full Text] [Related]
15. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR.
Zeng W; Zhu JF; Liu JY; Li YL; Dong X; Huang H; Shan L
Biomed Pharmacother; 2019 Mar; 111():476-484. PubMed ID: 30594787
[TBL] [Abstract][Full Text] [Related]
16. Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis.
Li Z; Qin X; Bian W; Li Y; Shan B; Yao Z; Li S
J Exp Clin Cancer Res; 2019 Nov; 38(1):477. PubMed ID: 31775815
[TBL] [Abstract][Full Text] [Related]
17. Metformin Inhibited Growth, Invasion and Metastasis of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo.
Liang F; Wang YG; Wang C
Cell Physiol Biochem; 2018; 51(3):1276-1286. PubMed ID: 30481793
[TBL] [Abstract][Full Text] [Related]
18. Effects and mechanisms of FBXO31 on Taxol chemoresistance in esophageal squamous cell carcinoma.
Lv L; Wang SC; Mo JY; Huang KL; Xu ML; Liu J
Biochem Biophys Res Commun; 2022 Jan; 586():129-136. PubMed ID: 34839191
[TBL] [Abstract][Full Text] [Related]
19. Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.
Mohammadi F; Javid H; Afshari AR; Mashkani B; Hashemy SI
Mol Biol Rep; 2020 Jun; 47(6):4263-4272. PubMed ID: 32436041
[TBL] [Abstract][Full Text] [Related]
20. Long non‑coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway.
Yu X; Huang M; Yang G
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
